
Recent improvements in zzso therapies have reduced the zzso of acute rejection and increased patient zzso These agents may however contribute to higher rates of mortality due to an increased risk of cardiovascular disease or zzso zzso patients are in an zzso state, and have a reduced ability to combat the development of zzso The higher risk for the activity of zzso may also contribute to the higher zzso and the specific tumor types zzso Some zzso may have a direct zzso zzso In zzso data have demonstrated that zzso zzso zzso may have a direct effect on tumor growth and the development of zzso In contrast, zzso zzso have demonstrated in zzso zzso properties, perhaps via a potent zzso zzso Recent studies and registry analyses have confirmed that zzso zzso are associated with a reduced zzso of zzso zzso data demonstrated that an zzso zzso with or without a zzso is associated with a reduced zzso of cancer compared to regimens without zzso zzso The zzso Maintenance zzso study demonstrated that patients receiving zzso zzso therapy after zzso withdrawal at 3 months had a reduced zzso of zzso at 5 years zzso compared with those who continued a regimen including zzso In the zzso study, patients converted to zzso had significantly lower zzso rates zzso at 24 months compared with those who continued zzso therapy zzso zzso The elimination of zzso and the introduction of zzso may therefore have a role in reducing the risk of cancer in zzso zzso 

